AstraZeneca expanding R&D operation in India

1871 Investors following AstraZeneca. Share this News with them.

0

Like this story, share it with millions of investors on M3

AstraZeneca expanding R&D operation in India

Pharma major AstraZeneca has new plans for India. Louis Schweitzer, AstraZeneca's Non-Executive Chairman has said that the company is expanding its R&D operations here to develop a new TB drug.

Post your opinion here

 

0

Tweet

Share on Tumblr

Excerpts from Power Breakfast on CNBC-TV18 Watch the full show » RELATED NEWS Healthy times ahead for pharma: Experts Intas Biopharmaceuticals joins hands with Progenetics Sun Pharma pumps up 4.13% Industry opposes new drug policy ALSO READ See latest News about AstraZeneca See previous management interviews See what other Experts & Brokerages are saying about AstraZeneca Nifty BSE | NSE 25/05/12 Are Mutual Funds betting on Nifty?

Pharma major AstraZeneca has new plans for India. Louis Schweitzer, AstraZeneca's Non-Executive Chairman has said that the company is expanding its R&D operations here to develop a new TB drug.

The process development research base will be set up with USD 15 million investment and it will be operational in a year. The new tuberculosis drug may be ready for development by 2010.

AstraZeneca is looking at 20% growth for the Indian subsidiary.